{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:55:59Z","timestamp":1768982159841,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T00:00:00Z","timestamp":1365552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/2162-3619-2-11","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T12:14:42Z","timestamp":1365596082000},"source":"Crossref","is-referenced-by-count":19,"title":["Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment"],"prefix":"10.1186","volume":"2","author":[{"given":"Fung","family":"Kwong-Lam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan Godfrey","family":"Chi-Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,10]]},"reference":[{"key":"52_CR1","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","volume":"371","author":"CH Pui","year":"2008","unstructured":"Pui CH, Robison LL, Look AT: Acute lymphoblastic leukemia. Lancet 2008, 371: 1030\u20131043. 10.1016\/S0140-6736(08)60457-2","journal-title":"Lancet"},{"issue":"2","key":"52_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3324\/haematol.2008.004150","volume":"4","author":"S Chiaretti","year":"2009","unstructured":"Chiaretti S, Fo\u00e0 R: T-cell acute lymphoblastic leukemia. Hematologica 2009,4(2):160\u2013162.","journal-title":"Hematologica"},{"issue":"6","key":"52_CR3","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","volume":"120","author":"CH Pui","year":"2012","unstructured":"Pui CH, Mullighan CG, Evans WE, Relling MV: Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood 2012,120(6):1165\u20131174. 10.1182\/blood-2012-05-378943","journal-title":"Blood"},{"issue":"20","key":"52_CR4","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","volume":"22","author":"X Thomas","year":"2004","unstructured":"Thomas X, Boiron JM, Huguet F, Dombret H, Bradstock K, Vey N: Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004,22(20):4075\u20134086. 10.1200\/JCO.2004.10.050","journal-title":"J Clin Oncol"},{"issue":"4","key":"52_CR5","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1172\/JCI30235","volume":"117","author":"S Iwamoto","year":"2007","unstructured":"Iwamoto S, Mihara K, Downing JR, Pui CH, Campana D: Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest 2007,117(4):1049\u20131057. 10.1172\/JCI30235","journal-title":"J Clin Invest"},{"issue":"3","key":"52_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-2141.2004.05200.x","volume":"127","author":"J Li","year":"2004","unstructured":"Li J, Law HK, Lau YL, Chan GC: Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br J Hematol 2004,127(3):326\u2013334. 10.1111\/j.1365-2141.2004.05200.x","journal-title":"Br J Hematol"},{"key":"52_CR7","volume-title":"Vincristine sulfate (for injection) prescribing information","author":"Hospira Inc","year":"2007","unstructured":"Hospira Inc: Vincristine sulfate (for injection) prescribing information. 2007. [\n                    http:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=49596de6-ab18\u201349d1\u20139e5b-30968fc21c36\n                    \n                  ]"},{"issue":"3","key":"52_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3109\/10428190903406798","volume":"51","author":"KL Fung","year":"2010","unstructured":"Fung KL, Liang RH, Chan GC: Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells. Leuk Lymphoma 2010,51(3):515\u2013522. 10.3109\/10428190903406798","journal-title":"Leuk Lymphoma"},{"issue":"5\u20136","key":"52_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3109\/10428199509112198","volume":"19","author":"GJ Kaspers","year":"1995","unstructured":"Kaspers GJ, Pieters R, Van Zantwijk CH, Van Wering ER, Veerman AJ: Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells. Leuk Lymphoma 1995,19(5\u20136):407\u2013416.","journal-title":"Leuk Lymphoma"},{"issue":"25","key":"52_CR10","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1182\/blood-2009-12-258822","volume":"115","author":"CP Hernandez","year":"2010","unstructured":"Hernandez CP, Morrow K, Lopez-Barcons LA, Zabaleta J, Sierra R, Velasco C, Cole J, Rodriguez PC: Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood 2010,115(25):5314\u20135221.","journal-title":"Blood"},{"issue":"3","key":"52_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/leu.2012.247","volume":"27","author":"K Morow","year":"2013","unstructured":"Morow K, Hernandez CP, Raver P, Del L, Wilk AM, Majumdar S, Wyczechowska , Reiss K, Rodriguez PC: Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia. Leukemia 2013,27(3):569\u2013577. 10.1038\/leu.2012.247","journal-title":"Leukemia"},{"key":"52_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1158\/0008-5472.CAN-06-1945","volume":"67","author":"PNM Cheng","year":"2007","unstructured":"Cheng PNM, Lam TL, Lam WM, Tsui SM, Cheng AWM, Lo WH, Leung YC: Pegylated decombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. Can Res 2007, 67: 309\u2013317. 10.1158\/0008-5472.CAN-06-1945","journal-title":"Can Res"},{"key":"52_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1756-8722-5-17","volume":"5","author":"EC Hsueh","year":"2012","unstructured":"Hsueh EC, Knebel SM, Lo WH, Leung YC, Cheng PN, Hsueh CT: Deprivation of arginine by recombinant human arginase in prostate cancer cells. J Hematol Oncol 2012, 5: 17\u201322. 10.1186\/1756-8722-5-17","journal-title":"J Hematol Oncol"},{"key":"52_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/sj.bjc.6601134","volume":"89","author":"DN Wheatley","year":"2003","unstructured":"Wheatley DN, Campbell E: Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells. Br J Cancer 2003, 89: 573\u2013576. 10.1038\/sj.bjc.6601134","journal-title":"Br J Cancer"},{"key":"52_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1476-4598-9-129","volume":"9","author":"L Kucerova","year":"2010","unstructured":"Kucerova L, Matuskova M, Hlubinova K, Altanerova Vand , Altaner C: Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer 2010, 9: 129\u2013143. 10.1186\/1476-4598-9-129","journal-title":"Mol Cancer"},{"issue":"1","key":"52_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/stem.559","volume":"29","author":"AH Klopp","year":"2011","unstructured":"Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F: Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem cells 2011,29(1):11\u201319. 10.1002\/stem.559","journal-title":"Stem cells"},{"key":"52_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.stem.2008.08.008","volume":"3","author":"AI Caplan","year":"2008","unstructured":"Caplan AI: All MSCs are pericytes? Cell Stem Cell 2008, 3: 229\u2013230. 10.1016\/j.stem.2008.08.008","journal-title":"Cell Stem Cell"},{"key":"52_CR18","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1182\/blood-2003-09-3243","volume":"103","author":"S Chiaretti","year":"2004","unstructured":"Chiaretti S, Li X, Gentleman R, Vitale A, Vignetti M, Mandelli F, Ritz J, Foa R: Gene Expression Profile of Adult T Cell Acute Lymphocytic Leukemia Identifies Distinct Subsets of Patients with Different Response to Therapy and Survival. Blood 2004, 103: 2771\u20132778. 10.1182\/blood-2003-09-3243","journal-title":"Blood"},{"issue":"4","key":"52_CR19","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3324\/haematol.12098","volume":"93","author":"MT Scupoli","year":"2008","unstructured":"Scupoli MT, Donadelli M, Cioffi F, Rossi M, Perbellini O, Malpeli G, Corbioli S, Vinante F, Krampera M, Palmieri M, Scarpa A, Ariola C, Fo\u00e0 R, Pizzolo G: Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12\/CXCR4 axis and the NF-kappaB and JNK\/AP-1 pathways. Hematologica 2008,93(4):524\u2013532. 10.3324\/haematol.12098","journal-title":"Hematologica"},{"issue":"1","key":"52_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jcp.21653","volume":"219","author":"RD Sumanasinghe","year":"2009","unstructured":"Sumanasinghe RD, Pfeiler TW, Monteiro-Riviere NA, Loboa EG: Expression of proinflammatory cytokines by human mesenchymal stem cells in response to cyclic tensile strain. J Cell Physiol 2009,219(1):77\u201383. 10.1002\/jcp.21653","journal-title":"J Cell Physiol"},{"issue":"1","key":"52_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2567.2004.02005.x","volume":"114","author":"J Ivanoff","year":"2005","unstructured":"Ivanoff J, Tame T, Sundqvist KG: The role of chemokines and extracellular matrix components in the migration of T lymphocytes into three-dimensional substrata. Immunology 2005,114(1):53\u201362. 10.1111\/j.1365-2567.2004.02005.x","journal-title":"Immunology"},{"issue":"5","key":"52_CR22","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/S0016-5085(03)00170-7","volume":"124","author":"P Crenn","year":"2003","unstructured":"Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, Messing B: Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 2003,124(5):1210\u20131219. 10.1016\/S0016-5085(03)00170-7","journal-title":"Gastroenterology"},{"issue":"4","key":"52_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.exphem.2010.01.006","volume":"38","author":"L Prata Kde","year":"2010","unstructured":"Prata Kde L, Orellana MD, De Santis GC, Kashima S, Fontes AM, Carrara R, Palma PV, Neder L, Covas DT: Effects of high-dose chemotherapy on bone marrow multipotent mesenchymal stromal cells isolated from lymphoma patients. Exp Hematol 2010,38(4):292\u2013300. 10.1016\/j.exphem.2010.01.006","journal-title":"Exp Hematol"},{"issue":"7","key":"52_CR24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00277-009-0896-2","volume":"89","author":"K Kemp","year":"2010","unstructured":"Kemp K, Morse R, Wexler S, Cox C, Mallam E, Hows J, Donaldson C: Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy. Ann Hematol 2010,89(7):101\u2013113.","journal-title":"Ann Hematol"},{"key":"52_CR25","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1046\/j.1365-2141.2003.04217.x","volume":"120","author":"K Mihara","year":"2003","unstructured":"Mihara K, Imai C, Coustan-Smith E, Dome JS, Dominici M, Vanin E, Campana D: Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br J Hematol 2003, 120: 846\u2013849. 10.1046\/j.1365-2141.2003.04217.x","journal-title":"Br J Hematol"}],"container-title":["Experimental Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2162-3619-2-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2162-3619-2-11\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2162-3619-2-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T11:19:30Z","timestamp":1548155970000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/2162-3619-2-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,10]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1186\/2162-3619-2-11","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,10]]},"article-number":"11"}}